Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-17

FDA Approved: TETRABENAZINE — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex's generic tetrabenazine through an original application, expanding access to treatment for Huntington disease–related chorea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tetrabenazine (tetrabenazine)

Snippet

ORIG AP for TETRABENAZINE (TETRABENAZINE)